Loading...

Alexa Fluor® 700 anti-mouse CD3 Antibody Alexa Fluor® 700 anti-mouse CD3 Antibody

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_Alx700_021808
C57BL/6 mouse splenocytes stained with 17A2 Alexa Fluor® 700
  • 17A2_Alx700_021808
    C57BL/6 mouse splenocytes stained with 17A2 Alexa Fluor® 700
Compare all formats See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability Save
100216 100 µg NOK1774
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100215 25 µg NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD3 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  2. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  3. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  4. Steudler J, et al. 2022. Glia. 70:2045. PubMed
  5. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  6. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  7. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  8. Feng J, et al. 2022. Immunity. 55:405. PubMed
  9. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  10. Ke F, et al. 2023. Elife. 12:. PubMed
  11. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  12. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  13. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  14. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  15. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  16. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  17. Fisher E, et al. 2021. Front Immunol. 11:602254. PubMed
  18. Abdul-Careem MF, et al. 2012. PLoS One. 7:e32821. PubMed
  19. Wojno E, et al. 2011. J Immunol. 187:266. PubMed
  20. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  21. Toomer G, et al. 2022. Viruses. 14:. PubMed
  22. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  23. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  24. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  25. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  26. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  27. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  28. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  29. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  30. Zhang H, et al. 2020. Cancer Cell. 37(1):37-54.e9.. PubMed
  31. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  32. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  33. Jiang H, et al. 2021. Oncoimmunology. 10:1943180. PubMed
  34. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  35. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  36. Watanabe K, et al. 2018. JCI Insight. 3. PubMed
  37. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  38. Levescot A, et al. 2021. J Clin Invest. 131:. PubMed
  39. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  40. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  41. Everard A, et al. 2014. Nat Commun. 5:5648. PubMed
  42. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  43. Li Q, et al. 2019. Front Pharmacol. 10:786. PubMed
  44. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  45. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  46. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  47. La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed
  48. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  49. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  50. Green WD, et al. 2022. J Leukoc Biol. 111:147. PubMed
  51. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  52. Li A, et al. 2020. J Virol. 94:00:00. PubMed
  53. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  54. Kiniry BE, et al. 2018. J Immunol. 200:1876. PubMed
  55. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  56. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  57. Mantilla-Rojas C, et al. 2022. Cancers (Basel). 14:. PubMed
  58. Bendtsen SK, et al. 2022. Oncoimmunology. 11:2026020. PubMed
  59. Bruder J, et al. 2017. Mol Ther Methods Clin Dev. 10.1016/j.omtm.2017.08.003. PubMed
  60. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  61. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  62. Moguche AO et al. 2017. Cell host & microbe. 21(6):695-706 . PubMed
  63. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  64. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  65. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  66. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  67. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  68. Agashe VV, et al. 2018. J Immunol. 201:772. PubMed
  69. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  70. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  71. Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
  72. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  73. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  74. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  75. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  76. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  77. Zaitseva M, et al. 2017. Antiviral Research. 10.1016/j.antiviral.2017.05.002. PubMed
  78. Tulyeu J, et al. 2021. Curr Protoc. 1:e283. PubMed
  79. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  80. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  81. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  82. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  83. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  84. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  85. Voeller J, et al. 2019. J Immunother Cancer. 0.530555556. PubMed
  86. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  87. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  88. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  89. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  90. Spencer AJ, et al. 2022. EBioMedicine. 77:103902. PubMed
  91. Chavez JS, et al. 2022. Cells. 11:. PubMed
  92. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  93. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  94. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  95. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  96. Rezende RM, et al. 2019. J Immunol. 203:2621. PubMed
  97. Parigger T, et al. 2021. Int J Mol Sci. 22:. PubMed
  98. Hendin HE, et al. 2022. NPJ Vaccines. 7:42. PubMed
  99. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  100. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  101. Samuelson DR, et al. 2021. Commun Biol. 4:997. PubMed
  102. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  103. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  104. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  105. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  106. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  107. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  108. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  109. Steudler J, et al. 2022. Glia. 70:2045. PubMed
  110. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  111. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  112. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  113. Feng J, et al. 2022. Immunity. 55:405. PubMed
  114. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  115. Ke F, et al. 2023. Elife. 12:. PubMed
  116. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  117. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  118. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  119. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  120. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  121. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  122. Fisher E, et al. 2021. Front Immunol. 11:602254. PubMed
  123. Abdul-Careem MF, et al. 2012. PLoS One. 7:e32821. PubMed
  124. Wojno E, et al. 2011. J Immunol. 187:266. PubMed
  125. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  126. Toomer G, et al. 2022. Viruses. 14:. PubMed
  127. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  128. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  129. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  130. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  131. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  132. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  133. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  134. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  135. Zhang H, et al. 2020. Cancer Cell. 37(1):37-54.e9.. PubMed
  136. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  137. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  138. Jiang H, et al. 2021. Oncoimmunology. 10:1943180. PubMed
  139. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  140. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  141. Watanabe K, et al. 2018. JCI Insight. 3. PubMed
  142. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  143. Levescot A, et al. 2021. J Clin Invest. 131:. PubMed
  144. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  145. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  146. Everard A, et al. 2014. Nat Commun. 5:5648. PubMed
  147. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  148. Li Q, et al. 2019. Front Pharmacol. 10:786. PubMed
  149. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  150. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  151. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  152. La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed
  153. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  154. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  155. Green WD, et al. 2022. J Leukoc Biol. 111:147. PubMed
  156. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  157. Li A, et al. 2020. J Virol. 94:00:00. PubMed
  158. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  159. Kiniry BE, et al. 2018. J Immunol. 200:1876. PubMed
  160. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  161. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  162. Mantilla-Rojas C, et al. 2022. Cancers (Basel). 14:. PubMed
  163. Bendtsen SK, et al. 2022. Oncoimmunology. 11:2026020. PubMed
  164. Bruder J, et al. 2017. Mol Ther Methods Clin Dev. 10.1016/j.omtm.2017.08.003. PubMed
  165. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  166. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  167. Moguche AO et al. 2017. Cell host & microbe. 21(6):695-706 . PubMed
  168. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  169. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  170. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  171. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  172. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  173. Agashe VV, et al. 2018. J Immunol. 201:772. PubMed
  174. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  175. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  176. Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
  177. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  178. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  179. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  180. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  181. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  182. Zaitseva M, et al. 2017. Antiviral Research. 10.1016/j.antiviral.2017.05.002. PubMed
  183. Tulyeu J, et al. 2021. Curr Protoc. 1:e283. PubMed
  184. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  185. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  186. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  187. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  188. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  189. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  190. Voeller J, et al. 2019. J Immunother Cancer. 0.530555556. PubMed
  191. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  192. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  193. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  194. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  195. Spencer AJ, et al. 2022. EBioMedicine. 77:103902. PubMed
  196. Chavez JS, et al. 2022. Cells. 11:. PubMed
  197. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  198. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  199. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  200. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  201. Rezende RM, et al. 2019. J Immunol. 203:2621. PubMed
  202. Parigger T, et al. 2021. Int J Mol Sci. 22:. PubMed
  203. Hendin HE, et al. 2022. NPJ Vaccines. 7:42. PubMed
  204. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  205. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  206. Samuelson DR, et al. 2021. Commun Biol. 4:997. PubMed
  207. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  208. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  209. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  210. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
RRID
AB_493697 (BioLegend Cat. No. 100216)
AB_493696 (BioLegend Cat. No. 100215)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Test 17A2 5 17A2
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 2    Revision Date: 06.27.2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
17A2 (See other available formats)
Regulatory Status
RUO
Other Names
T cell antigen receptor complex, T3
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
17A2_Alx700_021808
C57BL/6 mouse splenocytes stained with 17A2 Alexa Fluor® 700
  • 17A2_Alx700_021808
    C57BL/6 mouse splenocytes stained with 17A2 Alexa Fluor® 700
Compare all formats See Alexa Fluor® 700 spectral data
Cat # Size Price Quantity Check Availability Save
100216 100 µg NOK1774
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100215 25 µg NOK776
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
γδTCR-positive T-T hybridoma D1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD3 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.

Application References
  1. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  2. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  2. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  3. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  4. Steudler J, et al. 2022. Glia. 70:2045. PubMed
  5. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  6. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  7. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  8. Feng J, et al. 2022. Immunity. 55:405. PubMed
  9. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  10. Ke F, et al. 2023. Elife. 12:. PubMed
  11. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  12. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  13. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  14. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  15. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  16. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  17. Fisher E, et al. 2021. Front Immunol. 11:602254. PubMed
  18. Abdul-Careem MF, et al. 2012. PLoS One. 7:e32821. PubMed
  19. Wojno E, et al. 2011. J Immunol. 187:266. PubMed
  20. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  21. Toomer G, et al. 2022. Viruses. 14:. PubMed
  22. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  23. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  24. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  25. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  26. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  27. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  28. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  29. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  30. Zhang H, et al. 2020. Cancer Cell. 37(1):37-54.e9.. PubMed
  31. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  32. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  33. Jiang H, et al. 2021. Oncoimmunology. 10:1943180. PubMed
  34. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  35. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  36. Watanabe K, et al. 2018. JCI Insight. 3. PubMed
  37. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  38. Levescot A, et al. 2021. J Clin Invest. 131:. PubMed
  39. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  40. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  41. Everard A, et al. 2014. Nat Commun. 5:5648. PubMed
  42. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  43. Li Q, et al. 2019. Front Pharmacol. 10:786. PubMed
  44. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  45. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  46. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  47. La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed
  48. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  49. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  50. Green WD, et al. 2022. J Leukoc Biol. 111:147. PubMed
  51. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  52. Li A, et al. 2020. J Virol. 94:00:00. PubMed
  53. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  54. Kiniry BE, et al. 2018. J Immunol. 200:1876. PubMed
  55. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  56. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  57. Mantilla-Rojas C, et al. 2022. Cancers (Basel). 14:. PubMed
  58. Bendtsen SK, et al. 2022. Oncoimmunology. 11:2026020. PubMed
  59. Bruder J, et al. 2017. Mol Ther Methods Clin Dev. 10.1016/j.omtm.2017.08.003. PubMed
  60. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  61. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  62. Moguche AO et al. 2017. Cell host & microbe. 21(6):695-706 . PubMed
  63. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  64. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  65. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  66. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  67. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  68. Agashe VV, et al. 2018. J Immunol. 201:772. PubMed
  69. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  70. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  71. Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
  72. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  73. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  74. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  75. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  76. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  77. Zaitseva M, et al. 2017. Antiviral Research. 10.1016/j.antiviral.2017.05.002. PubMed
  78. Tulyeu J, et al. 2021. Curr Protoc. 1:e283. PubMed
  79. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  80. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  81. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  82. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  83. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  84. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  85. Voeller J, et al. 2019. J Immunother Cancer. 0.530555556. PubMed
  86. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  87. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  88. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  89. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  90. Spencer AJ, et al. 2022. EBioMedicine. 77:103902. PubMed
  91. Chavez JS, et al. 2022. Cells. 11:. PubMed
  92. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  93. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  94. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  95. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  96. Rezende RM, et al. 2019. J Immunol. 203:2621. PubMed
  97. Parigger T, et al. 2021. Int J Mol Sci. 22:. PubMed
  98. Hendin HE, et al. 2022. NPJ Vaccines. 7:42. PubMed
  99. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  100. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  101. Samuelson DR, et al. 2021. Commun Biol. 4:997. PubMed
  102. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  103. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  104. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  105. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  106. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  107. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  108. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  109. Steudler J, et al. 2022. Glia. 70:2045. PubMed
  110. Gary EN, et al. 2022. Cell Rep Med. 3:100693. PubMed
  111. Giannou AD, et al. 2023. Immunity. 56:125. PubMed
  112. Briukhovetska D, et al. 2023. Immunity. 56:143. PubMed
  113. Feng J, et al. 2022. Immunity. 55:405. PubMed
  114. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  115. Ke F, et al. 2023. Elife. 12:. PubMed
  116. Saha S, et al. 2023. Sci Rep. 13:4609. PubMed
  117. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  118. Kwong Chung CK, et al. 2017. Immunology. 150:221. PubMed
  119. Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed
  120. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  121. Groenen AG, et al. 2022. J Lipid Res. 63:100167. PubMed
  122. Fisher E, et al. 2021. Front Immunol. 11:602254. PubMed
  123. Abdul-Careem MF, et al. 2012. PLoS One. 7:e32821. PubMed
  124. Wojno E, et al. 2011. J Immunol. 187:266. PubMed
  125. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  126. Toomer G, et al. 2022. Viruses. 14:. PubMed
  127. Jiang W, et al. 2022. Front Immunol. 13:878832. PubMed
  128. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  129. Chow MT et al. 2019. Immunity. 50(6):1498-1512 . PubMed
  130. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  131. Teng ZX, et al. 2022. J Inflamm Res. 15:3187. PubMed
  132. Yu M, et al. 2021. J Clin Invest. 131:. PubMed
  133. Yang Y, et al. 2021. Nat Commun. 12:525. PubMed
  134. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  135. Zhang H, et al. 2020. Cancer Cell. 37(1):37-54.e9.. PubMed
  136. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  137. Gary EN, et al. 2021. iScience. 24(7):102699. PubMed
  138. Jiang H, et al. 2021. Oncoimmunology. 10:1943180. PubMed
  139. Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed
  140. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  141. Watanabe K, et al. 2018. JCI Insight. 3. PubMed
  142. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  143. Levescot A, et al. 2021. J Clin Invest. 131:. PubMed
  144. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  145. Tyagi AM, et al. 2021. eLife. 10:00. PubMed
  146. Everard A, et al. 2014. Nat Commun. 5:5648. PubMed
  147. Leylek R, et al. 2019. Cell Rep. 29:3736. PubMed
  148. Li Q, et al. 2019. Front Pharmacol. 10:786. PubMed
  149. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  150. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  151. Reese B, et al. 2020. J Immunol. 205:3218. PubMed
  152. La Rose AM, et al. 2021. Mol Metab. 53:101265. PubMed
  153. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  154. Kuhn JA, et al. 2021. Elife. 10:. PubMed
  155. Green WD, et al. 2022. J Leukoc Biol. 111:147. PubMed
  156. Sharma M, et al. 2020. Circ Res. 127:335. PubMed
  157. Li A, et al. 2020. J Virol. 94:00:00. PubMed
  158. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  159. Kiniry BE, et al. 2018. J Immunol. 200:1876. PubMed
  160. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  161. Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
  162. Mantilla-Rojas C, et al. 2022. Cancers (Basel). 14:. PubMed
  163. Bendtsen SK, et al. 2022. Oncoimmunology. 11:2026020. PubMed
  164. Bruder J, et al. 2017. Mol Ther Methods Clin Dev. 10.1016/j.omtm.2017.08.003. PubMed
  165. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  166. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  167. Moguche AO et al. 2017. Cell host & microbe. 21(6):695-706 . PubMed
  168. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  169. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  170. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  171. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  172. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  173. Agashe VV, et al. 2018. J Immunol. 201:772. PubMed
  174. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  175. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  176. Williams JB, et al. 2020. Nat Commun. 0.876388889. PubMed
  177. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  178. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  179. Jaako P, et al. 2016. Leukemia. 10.1038/leu.2016.159. PubMed
  180. Muchenditsi A, et al. 2017. Am J Physiol Gastrointest Liver Physiol. 313:G39. PubMed
  181. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  182. Zaitseva M, et al. 2017. Antiviral Research. 10.1016/j.antiviral.2017.05.002. PubMed
  183. Tulyeu J, et al. 2021. Curr Protoc. 1:e283. PubMed
  184. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  185. Moufarrij S, et al. 2020. Sci Rep. 10:3470. PubMed
  186. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  187. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  188. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  189. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  190. Voeller J, et al. 2019. J Immunother Cancer. 0.530555556. PubMed
  191. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  192. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  193. Seenappa LM, et al. 2022. NPJ Vaccines. 7:128. PubMed
  194. Schulze J, et al. 2021. Stroke. 52:2939. PubMed
  195. Spencer AJ, et al. 2022. EBioMedicine. 77:103902. PubMed
  196. Chavez JS, et al. 2022. Cells. 11:. PubMed
  197. Mykkänen O, et al. 2014. PLoS One. 9:114790. PubMed
  198. Platteel ACM, et al. 2018. Front Immunol. 1.544444444. PubMed
  199. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  200. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  201. Rezende RM, et al. 2019. J Immunol. 203:2621. PubMed
  202. Parigger T, et al. 2021. Int J Mol Sci. 22:. PubMed
  203. Hendin HE, et al. 2022. NPJ Vaccines. 7:42. PubMed
  204. Kong IY, et al. 2020. Cell Rep. 33:108290. PubMed
  205. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  206. Samuelson DR, et al. 2021. Commun Biol. 4:997. PubMed
  207. Jiang W, et al. 2021. Cell Rep. 37:110112. PubMed
  208. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
  209. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  210. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
RRID
AB_493697 (BioLegend Cat. No. 100216)
AB_493696 (BioLegend Cat. No. 100215)

Antigen Details

Structure
Ig superfamily, CD3/TCR, 20 kD
Distribution

Thymocytes (differentiation dependent), mature T cells, NK-T cells

Function
Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor
Peptide antigen/MHC-complex
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.

Gene ID
12502 View all products for this Gene ID
UniProt
View information about CD3 on UniProt.org

Other Formats

View All CD3 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 711™ anti-mouse CD3 17A2 FC
Biotin anti-mouse CD3 17A2 FC,IHC-F
PE/Dazzle™ 594 anti-mouse CD3 17A2 FC
APC/Fire™ 750 anti-mouse CD3 17A2 FC
Brilliant Violet 750™ anti-mouse CD3 17A2 FC
TotalSeq™-A0182 anti-mouse CD3 17A2 PG
Spark Blue™ 550 anti-mouse CD3 17A2 FC
TotalSeq™-B0182 anti-mouse CD3 17A2 PG
Spark NIR™ 685 anti-mouse CD3 17A2 FC
TotalSeq™-C0182 anti-mouse CD3 17A2 PG
APC/Fire™ 810 anti-mouse CD3 17A2 FC
PE/Fire™ 640 anti-mouse CD3 17A2 FC
Spark YG™ 570 anti-mouse CD3 17A2 IHC-F
PE/Fire™ 700 anti-mouse CD3 17A2 FC
FITC anti-mouse CD3 17A2 FC
PE anti-mouse CD3 17A2 FC
Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Test 17A2 5 17A2
Alexa Fluor® 488 anti-mouse CD3 17A2 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse CD3 17A2 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD3 17A2 FC
Alexa Fluor® 700 anti-mouse CD3 17A2 FC
PerCP/Cyanine5.5 anti-mouse CD3 17A2 FC
PE/Cyanine7 anti-mouse CD3 17A2 FC
APC/Cyanine7 anti-mouse CD3 17A2 FC
Brilliant Violet 570™ anti-mouse CD3 17A2 FC
Brilliant Violet 650™ anti-mouse CD3 17A2 FC
Brilliant Violet 421™ anti-mouse CD3 17A2 FC,ICC
Brilliant Violet 785™ anti-mouse CD3 17A2 FC
Brilliant Violet 510™ anti-mouse CD3 17A2 FC
APC anti-mouse CD3 17A2 FC
Ultra-LEAF™ Purified anti-mouse CD3 17A2 FC,IHC-F,IP,ICC
Brilliant Violet 605™ anti-mouse CD3 17A2 FC
Alexa Fluor® 594 anti-mouse CD3 17A2 IHC-F,FC,3D IHC,SB
PE/Cyanine5 anti-mouse CD3 17A2 FC
Spark Blue™ 574 anti-mouse CD3 Antibody 17A2 FC
Spark Violet™ 423 anti-mouse CD3 17A2 FC
PE/Fire™ 810 anti-mouse CD3 17A2 FC
Spark Red™ 718 anti-mouse CD3 17A2 FC
Spark UV™ 387 anti-mouse CD3 17A2 FC
PerCP/Fire™ 780 anti-mouse CD3 Antibody 17A2 FC
PerCP anti-mouse CD3 Antibody 17A2 FC
Spark YG™ 581 anti-mouse CD3 (Flexi-Fluor™) 17A2 FC
Spark YG™ 593 anti-mouse CD3 (Flexi-Fluor™) Antibody 17A2 FC
Spark PLUS B488™ anti-mouse CD3 17A2 FC
Go To Top Version: 2    Revision Date: 06.27.2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account